Location History:
- Indianapolis, IN (US) (1990)
- Zionsville, IN (US) (1988 - 1993)
- Monrovia, IN (US) (1991 - 2002)
Company Filing History:
Years Active: 1988-2002
Title: Brigitte E. Schoner: A Pioneer in Biopharmaceutical Innovations
Introduction: Brigitte E. Schoner, based in Monrovia, Indiana, has made significant contributions to the field of biopharmaceuticals through her innovative research and inventions. With an impressive portfolio of 21 patents, Schoner's work focuses on genetic and protein-based therapies that aim to address major health challenges.
Latest Patents: Among her latest patents, Schoner has developed crucial technologies such as the "DNA Encoding Rhesus ob Protein." This invention includes isolated nucleic acid molecules essential for encoding a Rhesus ob gene product that plays a critical role in regulating obesity in mammals. Furthermore, she has disclosed vectors and methods for effectively expressing this gene product. Another notable invention is related to "Beta-Lipotropin Methods," which encompasses isolated nucleic acids, vectors, and transformed host cells, along with analogs and functional fragments concerning beta-lipotropin. This invention also provides pharmaceutical compositions that contain beta-lipotropin or its fragments and methods for treating diabetes and its complications through the administration of effective amounts of this protein.
Career Highlights: Brigitte E. Schoner currently works at Eli Lilly and Company, a leading global pharmaceutical company recognized for its commitment to improving global health through innovative medicines. Her role at Eli Lilly allows her to work on cutting-edge projects that combine scientific research with patient care.
Collaborations: Throughout her career, Schoner has had the opportunity to collaborate with esteemed colleagues, including Margret B. Basinski and Richard Dennis DiMarchi. These collaborations have enriched her research endeavors and led to advancements in various biopharmaceutical applications.
Conclusion: Brigitte E. Schoner stands out as a formidable inventor in the realm of biopharmaceuticals, with her innovative patents contributing to the understanding and treatment of significant health issues like obesity and diabetes. Her work at Eli Lilly and her collaborations with fellow scientists highlight her dedication to pushing the boundaries of medical science. As she continues to innovate, the impact of her research will undoubtedly benefit countless individuals seeking effective treatments.